pharmacopeia
GET
/api/v1/drug/bisacodyl

Mechanism of action

Sourced from openFDA

Mechanism-of-action class: Unknown Cellular or Molecular Interaction.

Indications

Sourced from openFDA
  • Use for relief of occasional constipation and irregularity this product generally produces bowel movement in 15 minutes to 1 hourICD-10: K59.00

Dosage & administration

Sourced from openFDA

Directions Peel open plastic. Insert suppository into rectum, pointed end first. Retain about 15 to 20 minutes. adults and children 12 years of age and over 1 suppository in a single daily dose. children 6 to under 12 years of age ½ suppository in a single daily dose children under 6 years of age ask a doctor

Warnings & precautions

Sourced from openFDA

For rectal use only Ask a doctor before use if you have stomach pain, nausea or vomiting noticed a sudden change in bowel habits that lasts more than 2 weeks When using this product it may cause stomach discomfort, faintness, rectal burning and mild cramps Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after using this product. These could be signs of a serious condition. you need to use a laxative for more than 1 week If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Approval history

Sourced from openFDA
  • Aug 20, 2014ANDAANDA202217Novel Labs Inc

FAERS reports

View JSON
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
13,789 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
  1. 1Constipation1,53511%
  2. 2Nausea1,39910%
  3. 3Drug Ineffective1,38010%
  4. 4Off Label Use1,1448.3%
  5. 5Pain1,1428.3%
  6. 6Vomiting1,0217.4%
  7. 7Fall8566.2%
  8. 8Dyspnoea8496.2%
  9. 9Pneumonia8165.9%
  10. 10Fatigue8075.9%
  11. 11Death7915.7%
  12. 12Abdominal Pain7825.7%
  13. 13Macular Degeneration7815.7%
  14. 14Pyrexia7775.6%
  15. 15Anaemia7005.1%

Literature

View JSON

Recent PubMed references pinned to Bisacodyl as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

Clinical trials

View JSON

The 10 most recently updated of 113 ClinicalTrials.gov registrations naming Bisacodyl as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

Frequently asked questions

How does Bisacodyl work?
Mechanism-of-action class: Unknown Cellular or Molecular Interaction.
What is Bisacodyl used for?
According to FDA labeling, Bisacodyl carries indications including: Use for relief of occasional constipation and irregularity this product generally produces bowel movement in 15 minutes to 1 hour. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
What class of drug is Bisacodyl?
Bisacodyl is classified as Contact laxatives, Enemas, Stimulant Laxative, Unknown Cellular or Molecular Interaction, Increased Large Intestinal Motility, Stimulation Large Intestine Fluid/Electrolyte Secretion.
What are the brand names for Bisacodyl?
Bisacodyl is marketed under brand names including Alophen Reformulated Jan 2008, Bisac-Evac, Correct (New Formula), Correctol laxative Reformulated Feb 2008, Dulcolax, Evac-U-Gen Reformulated Jan 2008, Ex-lax Ultra, Feen-A-Mint Reformulated Jan 2008.
Note. Data for bisacodyl is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.

Search pharmacopeia

Search drugs, classes, and ingredients